Dr. Reddy's Laboratories Limited (Unit II)

Form 483 issued July 12, 2019 · Bollaram, India

Inspection
Jul 8 – Jul 12, 2019
Observations
1
Pages
5
FEI number
3005448030

In short: On July 12, 2019, FDA issued a Form 483 with 1 observation to Dr. Reddy's Laboratories Limited (Unit II) in Bollaram, India (FEI 3005448030) after an inspection that ran Jul 8 – Jul 12, 2019. The investigators were Christopher Keating and Ralph H. Vocque. Most observations concern quality system; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

1 of 1 observations on this 483 concern quality system.

Quality system1

Most cited: 21 CFR 211.192 (1×) · 211.198 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Investigations into product complaints and out-of-specification QC analytical results, related to finished API product quality…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Dr. Reddy's Laboratories Limited (Unit II)?

FDA listed 1 observation on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected Dr. Reddy's Laboratories Limited (Unit II)?

Christopher Keating and Ralph H. Vocque are named on this Form 483, for the inspection of Jul 8 – Jul 12, 2019. Each investigator has a profile showing what they cite most.

When was Dr. Reddy's Laboratories Limited (Unit II) inspected by FDA?

The inspection ran Jul 8 – Jul 12, 2019, and the Form 483 is dated July 12, 2019.

How do I get the full Form 483 for Dr. Reddy's Laboratories Limited (Unit II)?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free